FDA Allowance Of "Qualified" Plaque-Only Claims Urged By WhiteHill
This article was originally published in The Tan Sheet
Executive Summary
Inclusion of plaque-only claims "qualified with cosmetic benefits" in the eventual OTC monograph for antiplaque/antigingivitis drugs is urged by WhiteHill Oral Technologies in recent comments to FDA.
You may also be interested in...
Antiplaque Claims Spectrum Outlined By WhiteHill
Products carrying antiplaque-only claims should be permitted in the OTC antigingivitis/antiplaque monograph, WhiteHill Oral Technologies states in Nov. 24 comments to FDA
Antiplaque Claims Spectrum Outlined By WhiteHill
Products carrying antiplaque-only claims should be permitted in the OTC antigingivitis/antiplaque monograph, WhiteHill Oral Technologies states in Nov. 24 comments to FDA
Antigingivitis/Antiplaque Combination With Other Actives Excluded In ANPR
FDA's advance notice of proposed rulemaking for OTC antigingivitis/antiplaque products excludes the combination of antigingivitis/antiplaque ingredients with other oral health care ingredients. The 1notice was published in the May 29 Federal Register